Evidence map›Paper›PMID 26811819›Full record

ArticleIranian journal of public health2015

Survival Analysis of Breast Cancer Patients after Surgery with an Intermediate Event: Application of Illness-Death Model.

Morteza Hajihosseini, Javad Faradmal, Abdolazim Sadighi-Pashaki

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Application of Multi-State Model in Analyzing of Breast Cancer Data.Journal of research in health sciences · 2020
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Morteza HajihosseiniModeling of Noncommunicable Diseases Research Center, Dept. of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Javad FaradmalModeling of Noncommunicable Diseases Research Center, Dept. of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Abdolazim Sadighi-PashakiModeling of Noncommunicable Diseases Research Center, Dept. of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer (BC) is the second most commonly diagnosed cancer after lung cancer. Survival of BC patients is affected by intermediate events. This study was aimed to investigate the disease course of primary nonmetastatic BC patients with first recurrence of the tumor (FRT) as the intermediate event using the illness- death model.

methodsThis retrospective cohort study was conducted on 529 Iranian females with BC underwent surgery, from 1995 to 2013. Patients, tumor and treatment characteristics were collected from medical records of the patients. The illness-death model were used to investigate the relationship between these factors and survival time. Data were analyzed using version 3.1.1 of R software.

resultsThe risk of FRT in patients who had tumors size in the range of 2-5 cm and >5 cm was 1.3 and 3.5 times higher than that of patients with tumor size ≤2 cm, respectively (P<0.001). Furthermore, risk of death in patients aged ≥50 years was 1.6 times higher compared to patients aged less than 50 years (P =0.012). Risk of death after metastasis in patients with tumor size >5 cm was 2.1 times higher than patients with tumor size ≤2 cm (P =0.019).

conclusionsThe stage of the disease and tumor size have statistically significant effects on patients' survival before occurrence of the FRT. Furthermore, illness-death model was found to be a useful tool in modeling the disease course of BC patients.

Indexed as

Breast cancerIllness- death modelIntermediate eventsSurvival analysis

Identifiers

PMID26811819
PMCPMC4724741
OpenAlexW2266810971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.